A systematic review and meta-analysis of effects of spironolactone on blood pressure, glucose, lipids, renal function, fibrosis and inflammation in patients with hypertension and diabetes
Purpose Hypertension commonly co-exists with diabetes mellitus (DM), and both are closely related to adverse health outcomes. The activation of aldosterone and mineralocorticoid receptor (MR) may play important roles in this process. Therefore, we aim to evaluate the efficacy of MR antagonists on ca...
Main Authors: | Mengyue Lin, Mulalibike Heizati, Lin Wang, Muyesaier Nurula, Zhikang Yang, Zhongrong Wang, Reyila Abudoyreyimu, Zihao Wu, Nanfang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-05-01
|
Series: | Blood Pressure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/08037051.2021.1880881 |
Similar Items
-
Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
by: Sofia S. Pereira, et al.
Published: (2021-04-01) -
Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis
by: Byung Chul Yu, et al.
Published: (2018-09-01) -
Role of spironolactone in patients with resistant hypertension: A narrative review
by: Geeta Sheth, et al.
Published: (2021-01-01) -
Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients
by: Sun Z, et al.
Published: (2023-01-01) -
Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials
by: Jing Liu, et al.
Published: (2022-03-01)